Early Access — free while we kick the tires
EdgarHawk

Reents Scott T

EVP, CHIEF FINANCIAL OFFICER

Officer
1 filing analyzed · 1 company · Latest 2025-03-18

Companies

Company Buys Sells Direction
AbbVie Inc. ABBV 0 1 Net selling

Activity

March 2025
2025-03-18 AbbVie Inc. ABBV
medium
Sell
17,644 shares
$3,746,527
Significance 5/10

CFO Scott T Reents sold 17,644 shares of ABBV at $212.34 for $3.7M, reducing holdings by -60.4%.

Scott T Reents, EVP and Chief Financial Officer, executed an open-market sale of 17,644 shares at $212.34 on 2025-03-14, reducing his ABBV holdings from 29,221 to 11,577 shares. The sale occurred at a price within 1.3% of the 52-week high, and notably, the stock has appreciated 10.9% over the trailing 30 days and 23.6% over the trailing 90 days since the transaction. His cross-ticker track record shows a 100.00% well-timed rate on prior sells, and his singular prior ABBV sale in February 2024 was similarly well-timed with a -10.8% 90-day return following that trade. The substantial reduction in absolute position size warrants investor attention to whether operational or portfolio factors are driving the sale, though the timing relative to recent upward momentum and the CFO's demonstrated track record of selling before declines merit monitoring.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access